By Dermot Doherty Qiagen NV (QIA), the Dutch company whose tools are used to predict disease and isolate DNA, may make its second-biggest acquisition to date this year. Qiagen, based in Venlo, the Netherlands, is in talks with several diagnostics companies and may make a purchase in the “three-digit million dollar” range, Chief Financial Officer […]